Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.1 USD | -0.15% | -4.64% | -10.57% |
May. 09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
May. 09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 28K | Sales 2025 * | 29K | Capitalization | 200M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -51M | EV / Sales 2024 * | 7,143 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 6,897 x |
P/E ratio 2024 * |
-3.76
x | P/E ratio 2025 * |
-3.96
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.84% |
Latest transcript on INmune Bio, Inc.
1 day | -0.10% | ||
1 week | -9.97% | ||
Current month | -14.61% | ||
1 month | -10.45% | ||
3 months | -16.52% | ||
6 months | +7.90% | ||
Current year | -10.21% |
Managers | Title | Age | Since |
---|---|---|---|
David Moss
FOU | Founder | 54 | 15-08-31 |
Mark Lowdell
FOU | Founder | 61 | 15-08-31 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcia Allen
BRD | Director/Board Member | 73 | 19-11-18 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Scott Juda
BRD | Director/Board Member | 53 | 18-03-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 10.07 | -0.40% | 8 257 |
24-05-24 | 10.11 | -0.10% | 65,492 |
24-05-23 | 10.12 | -5.42% | 104,051 |
24-05-22 | 10.7 | +1.33% | 60,090 |
24-05-21 | 10.56 | -5.97% | 96,919 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.21% | 200M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.48% | 22.1B | |
-9.28% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- INMB Stock